4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0001174475-26-000004
Director sold 1,929 shares at $875.00 ($1,687,875)
- Director acquired 1,929 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BROWN MICHAEL S · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-30 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,929 | $725.89 | $1,400,242 | 3,309 | D |
| 2026-10-30 | Sale : show line 2 in the form 10b5-1 | −1,929 | $875.00 | $1,687,875 | 1,380 | D |
| Open-market sales · 1,929 sh · avg $875.00 · $1,687,875 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-30 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −1,929 | 0 | D |
Loading xslF345X06/edgardoc.xml…